Abbott-Alere South Korean antitrust review extended
Abbott Laboratories and Alere had their South Korean antitrust review extended by 90 days on April 20, Alere said Monday in a filing with the US Securities and Exchange Commission. It...To view the full article, register now.
Already a subscriber? Click here to view full article